Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Personality Addiction (July/August) | 2022

View Archived Issues

Supervised Drug Consumption

July 1, 2022

Christopher Clayton, MD, EdM and Deepti Anbarasan, MD.

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

Addiction and Borderline Personality Disorder

July 1, 2022

Ashley Pierson, PhD

Borderline personality disorder is highly comorbid with substance use disorders for reasons that are described by Dr. Pierson. She also reviews some basics of dialectical behavioral therapy, the gold standard treatment for borderline personality disorder, and shows us how therapeutic principles can be applied the treatment of addiction.

Should Prolonged Abstinence From Alcohol Be Required Before Liver Transplant?

July 1, 2022

Sonya Bakshi, MD and Deepti Anbarasan, MD.

Patients with alcohol-associated liver disease have traditionally needed to demonstrate an ability to refrain from drinking for 6 months before being deemed eligible for a liver transplant, despite the absence of research findings to support this requirement. Findings from this retrospective study show that a waiting period is not associated with improved outcomes.

Does Pioglitazone Lead to Reduced Alcohol Use?

July 1, 2022

Deepti Anbarasan, MD. and Nicholas Apping, MD

The hunt continues for effective medications for alcohol use disorder. Researchers here investigated the potential utility pioglitazone, a medication commonly used for diabetes management.

E-Cigarettes and Relapse to Cigarette Smoking

July 1, 2022

Noah Capurso, MD

Evidence for the use of e-cigarettes as smoking cessation agents continues to evolve. In this observational study, researchers find that e-cigarettes modestly increase the risk of relapse to smoking in patients who have managed to quit.